Linezolid and Glucose Injection
Product name: Linezolid and Glucose Injection
Main ingredients and chemical name: 100ml contains 0.2g Linezolid and 4.79g Glucose
Character The product is clear solution .
Indications
This product is used for the treatment of the following infections caused by specific microbial sensitive strains: Vancomycin-resistant Enterococcus faecium infections, nosocomial acquired pneumonia, complex skin and skin soft tissue infections, uncomplex skin and skin soft tissue infections, community acquired pneumonia and associated bacteremia.
Shijiazhuang No.4 Pharmaceutical Co., Ltd. was established in 1948, now it is a large-sized foreign invested enterprise and comprehensive medicine manufacturer in China, the capital is USD58 million, and with more than 3000 employees. The company can manufacture 7 series medicines of more than 100 kinds and specifications including infusions, capsules, granules, tablets, oral liquids and etc with GMP approval by SFDA of China. For the key product of large volume I.V solution, the yearly output has reached more than 1200 million bottles including 40 million bottles packing with the soft plastic bottles in the dosage of 500 ml/ 250 ml /100ml. Some index such as quality, variety, and yearly output are all in the leading position of this field in China.
The products have been sold to some countries and regions in South America, Africa, and Asia.
Audited Supplier 
){kind=link}